---
title: "uju_report_1"
output: html_document
date: "2025-11-22"
---

```{r setup, include=FALSE}
knitr::opts_chunk$set(echo = TRUE)
```


----------------Processing----------------------------------

```{r}
clinical <- read.delim("data_clinical_patient.txt", sep="\t", header=TRUE)
mutations <- read.delim("data_mutations.txt", sep="\t", header=TRUE)
rna <- read.csv("RNAseq_LIHC.csv", header=TRUE, row.names=1)

dim(clinical)
dim(mutations)
dim(rna)
head(rna[,1:5])

```

```{r}
### code from lab 7
# before analysis we first filtered the data to only count patients in all three datasets
extract_id <- function(tcga_codes) {
  tcga_codes <- as.character(tcga_codes)
  ids <- sub("^TCGA-[A-Z0-9]{2}-([A-Z0-9]{4}).*", "\\1", tcga_codes)
  return(ids)
}

extract_id_rnaseq <- function(tcga_codes) {
  tcga_codes <- as.character(tcga_codes)
  ids <- sub("^TCGA.[A-Z0-9]{2}.([A-Z0-9]{4}).*", "\\1", tcga_codes)
  return(ids)
}

#extract id
clinical_ids <- extract_id(clinical$X.Patient.Identifier)
clinical_ids <- clinical_ids[-(1:4)]   # removes first 4 header rows 

mutation_ids <- unique(extract_id(mutations$Tumor_Sample_Barcode))

rnaseq_ids <- unique(extract_id_rnaseq(colnames(rna)))

# finds the common ids. 
common_ids <- clinical_ids[
  clinical_ids %in% mutation_ids &
  clinical_ids %in% rnaseq_ids
]

cat("Number of patients present in ALL THREE datasets:", length(common_ids), "\n")
```

```{r}
clinical_filtered <- clinical[extract_id(clinical$X.Patient.Identifier) %in% common_ids, ]
mutation_filtered <- mutations[extract_id(mutations$Tumor_Sample_Barcode) %in% common_ids, ]
rnaseq_filtered <- rna[, extract_id_rnaseq(colnames(rna)) %in% common_ids]


cat("Filtered clinical:", nrow(clinical_filtered), "\n")
cat("Filtered mutation rows:", nrow(mutation_filtered), "\n")
cat("Filtered rnaseq columns:", ncol(rnaseq_filtered), "\n")
### guess some patients have more than 1 rna seq sample
```


--------------------------investigation 0-----------------------------------------------------------
```{r}
# Survival analysis by age 

# Convert age column to numeric
merged_data$Age <- as.numeric(merged_data$Diagnosis.Age)
summary(merged_data$Age)

# Remove missing age values (if any)
age_data <- merged_data %>% filter(!is.na(Age))

# Median age split
median_age <- median(age_data$Age, na.rm = TRUE)
median_age

age_data$Age_Group <- ifelse(age_data$Age >= median_age,
                             "Older",
                             "Younger")

table(age_data$Age_Group)

# Kaplan-Meier survival analysis
fit_age <- survfit(Surv(OS_time, OS_event) ~ Age_Group, data = age_data)

plot(fit_age, col=c("blue","red"), lty=1:2,
     main="Overall Survival by Age Group (LIHC)",
     xlab="Time (months)",
     ylab="Survival Probability")

legend("bottomleft",
       legend=levels(factor(age_data$Age_Group)),
       col=c("blue","red"), lty=1:2)

# Log-rank test
age_test <- survdiff(Surv(OS_time, OS_event) ~ Age_Group, data = age_data)
age_pval <- 1 - pchisq(age_test$chisq, length(age_test$n) - 1)
age_pval

#Median age = 61, so we split patients into:
#Younger: <61 years (n = 172)
# Older: ≥61 years (n = 180)
#The older group has a lower survival probability, especially after ~50 months.But the difference is not statistically significant.
#The trend still matches clinical expectations: older LIHC patients tend to do worse. But lacks statical significance...
```

```{r}
# analysis on tumor stage
stage_surv <- survfit(Surv(OS_time, OS_event) ~ Stage_simple, data = stage_data)

plot(stage_surv, col=1:4, lty=1,
     main="Survival by Tumor Stage (LIHC)")

legend("bottomleft", legend=levels(factor(stage_data$Stage_simple)),
       col=1:4, lty=1)

survdiff(Surv(OS_time, OS_event) ~ Stage_simple, data=stage_data)

### test to see wether ajcc tumor stage is associated with survival
#Stage I (n = 172), Stage II (n = 80), Stage III (n = 82)
#Log-rank test:χ² = 18.1, df = 2, p = 0.0001 --> meaning the stage-related survival differences are statistically significant.
# also, this trend is clinically to be expected as later-stage LIHC generally has worse outcomes
#dsf
```

```{r}
#some more clincal data anylsis
stage_data <- merged_data %>%
  mutate(Stage_raw = Neoplasm.Disease.Stage.American.Joint.Committee.on.Cancer.Code) %>%
  filter(!is.na(Stage_raw), Stage_raw != "") %>%
  mutate(
    Stage_simple = case_when(
      grepl("^STAGE I([^I]|$)", Stage_raw)   ~ "Stage I",   
      grepl("^STAGE II([^I]|$)", Stage_raw)  ~ "Stage II",  
      grepl("^STAGE III([^I]|$)", Stage_raw) ~ "Stage III", 
      grepl("^STAGE IV([^I]|$)", Stage_raw)  ~ "Stage IV",  
      TRUE ~ NA_character_
    )
  ) %>%
  filter(!is.na(Stage_simple))

# now add DSS time + event
stage_data$DSS_time <- suppressWarnings(
  as.numeric(stage_data$Months.of.disease.specific.survival)
)

stage_data$DSS_event <- ifelse(
  grepl("DECEASED", stage_data$Disease.specific.Survival.status),
  1,
  0
)

# keep only rows with valid DSS time
stage_dss <- stage_data %>% filter(!is.na(DSS_time))

library(survival)

fit_dss <- survfit(Surv(DSS_time, DSS_event) ~ Stage_simple, data = stage_dss)
plot(fit_dss,
     main = "Disease-specific survival by tumour stage",
     xlab = "Time (months)", ylab = "DSS probability")

survdiff(Surv(DSS_time, DSS_event) ~ Stage_simple, data = stage_dss)

#“Disease-specific survival (DSS) could not be analyzed because all patients in the filtered cohort had DSS_event = 0 (no recorded disease-specific deaths). This results in undefined statistics in the log-rank test. Therefore, DSS was excluded from downstream analyses. Overall survival (OS) was used as the primary clinical endpoint.” -chat
table(merged_data$DSS_event)
#so theres 0 desease specific deaths. so on to the next analysis. we cant use this one.
```

```{r}
table(merged_data$American.Joint.Committee.on.Cancer.Tumor.Stage.Code)

merged_data$T_stage <- merged_data$American.Joint.Committee.on.Cancer.Tumor.Stage.Code

# Simplify categories
merged_data$T_stage_simple <- case_when(
  grepl("^T1", merged_data$T_stage) ~ "T1",
  grepl("^T2", merged_data$T_stage) ~ "T2",
  grepl("^T3", merged_data$T_stage) ~ "T3",
  grepl("^T4", merged_data$T_stage) ~ "T4",
  TRUE ~ NA_character_
)

# larger and more invasive it is the higher number it is. T4 > T1
table(merged_data$T_stage_simple)

fit <- survfit(Surv(OS_time, OS_event) ~ T_stage_simple, data = merged_data)

plot(
  fit,
  col = c("#1b9e77", "#d95f02", "#7570b3", "#e7298a"),
  lwd = 2,
  lty = 1:4,
  xlab = "Time (months)",
  ylab = "Survival Probability",
  main = "Overall Survival by T-Stage (LIHC)"
)

legend(
  "bottomleft",
  legend = levels(factor(merged_data$T_stage_simple)),
  col = c("#1b9e77", "#d95f02", "#7570b3", "#e7298a"),
  lty = 1:4,
  lwd = 2,
  bty = "n"
)

# so this is good. very statiscally significant
#Survival analysis by AJCC T-stage (T1–T4) revealed a strong association between tumor invasiveness and patient outcomes. After extracting the primary tumor stage from the clinical dataset, patients were grouped into T1 (n = 174), T2 (n = 87), T3 (n = 75), and T4 (n = 13). Kaplan–Meier curves showed a clear stepwise decline in survival probability with increasing T-stage, with T4 patients demonstrating the poorest outcomes.

#A log-rank test confirmed that these differences were highly statistically significant (χ² = 35, p = 1×10⁻⁷). This indicates that tumor size and local invasion are strong prognostic factors in LIHC, consistent with known clinical behavior of hepatocellular carcinoma and with trends reported in the TCGA LIHC study. - chat.
```

```{r}

library(dplyr)
library(survival)

# 1. Clean and normalize sex labels
merged_data$Sex_clean <- toupper(trimws(merged_data$Sex))

# Check coding
table(merged_data$Sex_clean, useNA = "ifany")

# 2. Filter to valid sex + non-missing survival info
sex_data <- merged_data %>%
  filter(
    Sex_clean %in% c("MALE", "FEMALE"),
    !is.na(OS_time),
    !is.na(OS_event)
  )

# Sanity check
table(sex_data$Sex_clean)
summary(sex_data$OS_time)

# 3. Kaplan–Meier survival analysis by sex
fit_sex <- survfit(Surv(OS_time, OS_event) ~ Sex_clean, data = sex_data)

plot(
  fit_sex,
  col = c("blue", "red"),
  lwd = 2,
  lty = 1:2,
  xlab = "Time (months)",
  ylab = "Survival probability",
  main = "Overall Survival by Sex (LIHC)"
)

legend(
  "bottomleft",
  legend = levels(factor(sex_data$Sex_clean)),
  col = c("blue", "red"),
  lty = 1:2,
  lwd = 2,
  bty = "n"
)

# 4. Log-rank test
sex_test  <- survdiff(Surv(OS_time, OS_event) ~ Sex_clean, data = sex_data)
sex_pval  <- 1 - pchisq(sex_test$chisq, length(sex_test$n) - 1)
sex_test
sex_pval

#not so significant

```

----------------------Investigation 1-------------------
```{r}
# to count mutations per gene 
gene_counts <- mutation_filtered %>%
  count(Hugo_Symbol, name = "Mutation_Count") %>%
  arrange(desc(Mutation_Count))

head(gene_counts, 20)


top20_genes <- gene_counts %>% slice_max(Mutation_Count, n = 20)

ggplot(top20_genes, aes(x = reorder(Hugo_Symbol, Mutation_Count), y = Mutation_Count)) +
  geom_bar(stat = "identity", fill = "steelblue") +
  coord_flip() +
  labs(title = "Top 20 Most Mutated Genes in LIHC",
       x = "Gene",
       y = "Number of Mutations") +
  theme_minimal()
```

```{r}
## Investigation 1: Are high-frequency genes more mutated in advanced tumour stages?

library(dplyr)
library(ggplot2)

# 0. Make sure patient_id exists in mutation_nonsyn
if (!"patient_id" %in% colnames(mutation_nonsyn)) {
  mutation_nonsyn$patient_id <- extract_id(mutation_nonsyn$Tumor_Sample_Barcode)
}

# 1. Choose the 5 high-frequency genes (from your top20, excluding TTN/MUC16)
top5_genes <- c("TP53", "CTNNB1", "OBSCN", "PCLO", "ALB")

# 2. Build a simple clinical table with tumour stage
clinical_stage <- clinical_with_id %>%
  mutate(
    Stage_raw = Neoplasm.Disease.Stage.American.Joint.Committee.on.Cancer.Code,
    Stage_simple = case_when(
      grepl("^STAGE I([^I]|$)", Stage_raw)   ~ "Stage I",
      grepl("^STAGE II([^I]|$)", Stage_raw)  ~ "Stage II",
      grepl("^STAGE III([^I]|$)", Stage_raw) ~ "Stage III",
      grepl("^STAGE IV([^I]|$)", Stage_raw)  ~ "Stage IV",
      TRUE ~ NA_character_
    )
  ) %>%
  filter(!is.na(Stage_simple)) %>%
  select(patient_id, Stage_simple)

table(clinical_stage$Stage_simple)

# 3. Restrict mutation data to the 5 genes and 1 row per (patient, gene)
mut_top5 <- mutation_nonsyn %>%
  filter(Hugo_Symbol %in% top5_genes) %>%
  distinct(patient_id, Hugo_Symbol)

head(mut_top5)

# 4. Merge mutation info with stage
mut_stage <- mut_top5 %>%
  inner_join(clinical_stage, by = "patient_id")

head(mut_stage)

# 5. Count mutation frequencies per stage and gene
freq_table <- mut_stage %>%
  count(Stage_simple, Hugo_Symbol) %>%
  group_by(Stage_simple) %>%
  mutate(freq = n / sum(n))

freq_table

# 6. Plot: how these genes are distributed across stages
ggplot(freq_table, aes(x = Stage_simple, y = freq, fill = Hugo_Symbol)) +
  geom_bar(stat = "identity") +
  scale_y_continuous(labels = scales::percent) +
  labs(
    title = "Mutation frequencies of selected high-frequency genes across tumour stages",
    x = "Tumour stage",
    y = "Proportion of patients with mutations",
    fill = "Gene"
  ) +
  theme_minimal()

# 7. Chi-square test: Stage vs Gene (are distributions different?)
cont_table <- table(mut_stage$Stage_simple, mut_stage$Hugo_Symbol)
chisq_result <- chisq.test(cont_table)

chisq_result
chisq_result$p.value

```

-----------------------------invetigation 5(?) ----------------------------------------------------
```{r}
library(dplyr)
library(survival)

# 1. Define the driver gene panel (from LIHC literature)
driver_genes <- c(
  "TP53", "CTNNB1", "AXIN1", "RB1",
  "ALB", "APOB", "CPS1",
  "LZTR1", "SF3B1", "SMARCA4", "EEF1A1"
  # add "TERT" here if it exists in your mutation data
)

# 2. Define non-synonymous classes (same idea as your other analysis)
nonsyn_classes <- c(
  "Missense_Mutation",
  "Nonsense_Mutation",
  "Frame_Shift_Del",
  "Frame_Shift_Ins",
  "In_Frame_Del",
  "In_Frame_Ins",
  "Splice_Site",
  "Translation_Start_Site",
  "Nonstop_Mutation"
)

# 3. Make sure Patient_ID exists in mutation_filtered
mutation_filtered$Patient_ID <- substr(mutation_filtered$Tumor_Sample_Barcode, 1, 12)

# 4. Keep only non-synonymous driver gene mutations
driver_mutations <- mutation_filtered %>%
  filter(
    Variant_Classification %in% nonsyn_classes,
    Hugo_Symbol %in% driver_genes
  ) %>%
  distinct(Patient_ID, Hugo_Symbol)   # one row per patient–gene pair

head(driver_mutations)

# 5. Count how many distinct driver genes are mutated per patient
driver_counts <- driver_mutations %>%
  count(Patient_ID, name = "n_driver_genes")

head(driver_counts)

# 6. Merge driver counts into clinical + survival data
surv_df <- merged_data %>%
  left_join(driver_counts, by = "Patient_ID") %>%
  mutate(
    # patients with no driver mutations get 0
    n_driver_genes = ifelse(is.na(n_driver_genes), 0L, n_driver_genes),
    DriverGroup = ifelse(
      n_driver_genes >= 2,
      "2+ driver mutations",
      "0–1 driver mutation"
    )
  ) %>%
  # ensure survival info is complete
  filter(!is.na(OS_time), !is.na(OS_event))

table(surv_df$DriverGroup)
summary(surv_df$n_driver_genes)

# 7. Kaplan–Meier survival analysis: 0–1 vs 2+ driver mutations
fit_drivers <- survfit(Surv(OS_time, OS_event) ~ DriverGroup, data = surv_df)

plot(
  fit_drivers,
  col = c("blue", "red"),
  lwd = 2,
  lty = 1:2,
  xlab = "Time (months)",
  ylab = "Survival probability",
  main = "Overall survival by driver gene mutation burden"
)

legend(
  "bottomleft",
  legend = levels(factor(surv_df$DriverGroup)),
  col = c("blue", "red"),
  lty = 1:2,
  lwd = 2,
  bty = "n"
)

# 8. Log-rank test (are the survival curves different?)
driver_test <- survdiff(Surv(OS_time, OS_event) ~ DriverGroup, data = surv_df)
driver_pval <- 1 - pchisq(driver_test$chisq, length(driver_test$n) - 1)

driver_test
driver_pval
```

